Description:

• An oral allopathic prescription tablet designed to help regulate blood sugar spikes after meals and optimize long-term glucose management. 

Prescription: 

• Prescription Only Medicine (POM). 

Therapeutic Category: 

• Antidiabetic Agent / Dipeptidyl Peptidase-4 (DPP-4) Inhibitor. 

Active Ingredients/Composition:

•  Each single tablet contains 50 mg of Vildagliptin. (Note: A related combination variant containing Metformin also exists in the market under the name Glucanix-Met).
• Variant:
• Standard 50mg single-active tablet. Available in retail sizes like Glucanix 50mg 60-tablet packs. [1, 2]

Consume Type: 

• Oral use only (swallowed whole with a drink of water). Do not chew, break, or crush the tablet. 
• Directions/Usage:
  • Monotherapy/Dual Therapy: The standard therapeutic dose is either 50 mg once daily (in the morning) or 50 mg twice daily (one tablet in the morning and one in the evening).
  • Maximum Limits: Do not exceed a maximum daily limit of 100 mg per day (2 tablets).
  • Administration: Can be taken with or without food. If combined with other antidiabetics, taking it with meals reduces potential gastrointestinal shifts. 
• Common Side Effects: Dizziness (highly common), headache, nausea, trembling/sweating (if blood sugar drops too low when mixed with other drugs), and peripheral edema (mild fluid retention/swelling in the ankles). 

Package Type: 

• Aluminium-blister strips packed securely inside a retail cardboard dispensing carton, standardly distributed as a 60-tablet box. 

Storage Advice: 

• Store in a cool, dry place strictly below 25°C or 30°C. Keep the tablets inside their original blister packaging to protect them from environmental humidity and light degradation. Keep out of sight and reach of children.
• Safety Advice:
  • Liver Monitoring: Vildagliptin can rarely impact liver enzymes. Your physician must conduct liver function tests (LFTs) before initiating treatment and at regular clinical intervals during therapy.
  • Pancreatitis Warning: Discontinue use and contact an emergency room immediately if you develop severe, unrelenting, or radiating abdominal pain, as this can indicate a serious condition called acute pancreatitis.
  • Contraindications: Not recommended for use during pregnancy or breastfeeding, and requires severe dose reductions or restriction in cases of advanced liver or kidney failure. 

Manufacturer/Marketer: 

• Distributed and marketed through licensed regional channels by M&A Pharma / Add Pharma Ghana Limited. 

Country of Origin: 

• India / Europe (depending on localized pharmaceutical contract batch pipelines for the importing marketer).